Neuroone Medical Technologies is trading 6.11% down at $0.97 on October 1, 2026, with no new company-specific announcement identified to explain the decline.
- The latest cited distribution agreement was announced September 17.
- Treasury yields reaching multi-decade highs pressured equities, though major U.S. indexes were mixed. This may contribute to weakness but does not establish a direct cause for the stock’s move.